12 Week Evaluation of the Safety and Efficacy of 4 Dosing Strategies of CP-526,555 and Placebo for Smoking Cessation.
Clinical trial NCT00150254 · COMPLETED
Trial details
- NCT number
- NCT00150254
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2001-09-01
- Enrollment
- 625
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.